October 21, 2019
Circassia Pharmaceuticals launches Duaklir Pressair for Chronic Obstructive Pulmonary Disease (COPD)
Circassia Pharmaceuticals Inc. has launched Duaklir, aclidinium bromide and formoterol fumarate, for the maintenance treatment of patients with chronic obstructive…